Key result
Implantable BCI devices require better subject safeguards before investigational testing approval in Canada.
Why the study?
The regulatory framework for approval and investigational testing of implantable Brain-Computer Interface devices in Canada requires evaluation to ensure adequate safeguards for research subjects.
The article argues against the approval of implantable Brain-Computer Interface devices for investigational testing in Canada until better regulatory safeguards are established.
Answers are grounded in this paper and cite their sources.
Canadian BCI regulatory gaps require clinical caution; leaves open the need for strengthened investigational testing standards.
Implantable Brain-Computer Interface (BCI) devices are currently in clinical trials in the U.S., and their introduction into the Canada could follow in the next few years. This article provides an overview of the research, developments, design issues, and risks in BCIs and an analysis of the adequacy of the regulatory framework in place for the approval of medical devices in Canada, emphasizing device investigational testing. The article concludes that until better safeguards are in place, to best protect potential research subjects, BCIs should not be approved for investigational testing in Canada.
No takes yet. Share an insight, caveat, or question.
Sheri A. Alpert (2008) reported a review. Implantable Brain-Computer Interface (BCI) devices was evaluated. Implantable Brain-Computer Interface devices should not be approved for investigational testing in Canada until better safeguards are in place to protect potential research subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: